Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Breast 3Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 3099Neoplasms 2443Carcinoma, Non-Small-Cell Lung 1867Prostatic Neoplasms 1619Colorectal Neoplasms 1426Lung Neoplasms 1295Multiple Myeloma 929Neoplasm Metastasis 920Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 848Ovarian Neoplasms 799Melanoma 784Carcinoma, Hepatocellular 737Stomach Neoplasms 639Brain Neoplasms 636Recurrence 633Squamous Cell Carcinoma of Head and Neck 632Head and Neck Neoplasms 609Glioblastoma 567Lymphoma 540Uterine Cervical Neoplasms 539Triple Negative Breast Neoplasms 505Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Carcinoma, Renal Cell 499Hematologic Neoplasms 463Urinary Bladder Neoplasms 459Endometrial Neoplasms 459Colonic Neoplasms 442Lymphoma, Non-Hodgkin 436Sarcoma 434

Interventions

bazedoxifene 1Estrogens, Conjugated (USP) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Risk Reduction Behavior × 1 year × Clear all
NCT07630935 2026-06-05

NIGHT-SCAN

Assistance Publique - Hôpitaux de Paris

Not yet recruiting
100 enrolled
Breast

Breast Neoplasms, Risk Reduction Behavior

NCT00040222 2026-06-01

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

National Institutes of Health Clinical Center (CC)

Completed
377 enrolled
BreastGynecologic

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

NCT05732623 2026-04-24

DEMETRA

San Raffaele University

Recruiting
2,300 enrolled
Gastrointestinal

Colonic Neoplasms, Feeding Behavior, Rectal Neoplasms, Colorectal Neoplasms, Risk Reduction Behavior

NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

NCT03985852 2025-09-22

BRIDGE

University of Utah

Phase NA Completed
3,073 enrolled 7 charts

Neoplasms, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡